Cargando…
Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
Chronic kidney disease constitutes a major microvascular complication of diabetes mellitus. Accumulating data suggest that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) might have a role in the management of diabetic kidney disease (DKD). GLP-1 RAs appear to reduce the incidence of persisten...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503505/ https://www.ncbi.nlm.nih.gov/pubmed/32994865 http://dx.doi.org/10.4239/wjd.v11.i9.370 |